Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CBDHF Stock Summary
In the News
Hempfusion Wellness completes sale of assets and operations of probiotic business to Kadenwood
HempFusion Wellness Inc (TSX:CBD.U, OTCQX:CBDHF) said it has sold the assets and operations of its probiotic business, principally supplements sold under the Probulin brand name, under an asset purchase agreement dated November 21, 2022, with Kadenwood Inc, a private Delaware corporation. "Through this sale we have been able to reduce our debt and add operating cash, allowing the continued operation of our core CBD business,” the company said in a statement.
HempFusion Wellness reports a rise in Q4 and fiscal 2021 revenue amid declining costs
HempFusion (TSX:CBD.U, OTCQX:CBDHF) Wellness Inc has reported a strong rise in fourth-quarter and full-year 2021 revenue and said cost-saving initiatives will continue to reduce its operating expenses. The company said 4Q net revenue increased by 66% to $3.7 million from the same quarter a year earlier.
HempFusion Wellness announces brokered private placement to raise up to US$3.0M in aggregate gross proceeds
HempFusion (TSX:CBD.U, OTCQX:CBDHF) Wellness Inc has announced a brokered private placement to raise up to US$3.0 million in aggregate gross proceeds. Under the offering led by Research Capital Corporation as the sole agent and sole bookrunner, the company will offer up to 3,000 convertible debenture units at an issue price of US$1,000 per convertible debenture unit.
HempFusion Wellness says its hemp-derived CBD extract achieves “major regulatory milestone”
HempFusion (TSX:CBD.U, OTCQX:CBDHF) Wellness Inc announced that its hemp-derived CBD extract, developed through an exclusive joint venture with supply partner Verdant Nature, LLC, has achieved self-affirmed Generally Recognized as Safe (GRAS) status, positioning the company to meet or exceed US and global standards for CBD products. HempFusion (TSX:CBD.U, OTCQX:CBDHF) said it expects this “major regulatory milestone” to drive significant incremental revenue growth at the retail level.
HempFusion drives growth with its popular hemp-based CBD and probiotic products
Manufactures and sells hemp-based cannabidiol (CBD) and probiotic products in the US and Europe Brands widely distributed to around 4,000 retailers spread across all 50 US states Subsidiary Probulin Probiotics is one of the fastest-growing probiotics companies in the US What HempFusion does: HempFusion Wellness Inc (TSE:CBD.U) (OTCMKTS:CBFHF) (FRA:8OO) is a health and wellness supplement company utilizing the power of whole-food hemp nutrition. It manufactures, markets, and sells hemp-based cannabidiol (CBD) and probiotic products in the US and Europe.
HempFusion Wellness unveils $4M annual savings initiative and updates on retail growth
HempFusion (TSX:CBD.U, OTCQX:CBDHF) Wellness Inc has unveiled an initiative starting next year aimed at driving annual savings of $4 million and planting the business on the path to profitability. Project OPTIMIZE will focus on the firm's large family of brands and on three major areas - the optimiztion of workforce, supply-chain and marketing, the company said in a statement, in which it also updated on its retail growth expectations for 2022.
Hempfusion Wellness Inc. (CBDHF) CEO Dr. Jason Mitchell on Q3 2021 Results - Earnings Call Transcript
Hempfusion Wellness Inc. (CBDHF) CEO Dr. Jason Mitchell on Q3 2021 Results - Earnings Call Transcript
HempFusion Wellness reports year-over-year, triple-digit increase in 3Q revenue
HempFusion Wellness Inc reports that its third-quarter revenue increased year-over-year by triple-digits. In a statement, the company also said it ended the quarter with $5.4 million in cash.
HempFusion's Q3 Revenue Spikes 155% YoY, Accelerates Sales Activity in Q4
HempFusion Wellness Inc. (TSX:CBD) (OTCQB:CBDHF) (FWB: 8OO) announced financial results Monday for the third quarter ended September 30, 2021, revealing a net revenue of $3.1 million, up by 155% year-over-year and 154% sequentially. Q3 2021 Financial Highlights Excluding the recently completed acquisitions, HempFusion's revenue increased 31% year-over-year and 30% sequentially as the company makes strong progress on its retail distribution and e-commerce growth initiatives.
HempFusion drives growth with its popular hemp-based CBD and probiotic products
Manufactures and sells hemp-based cannabidiol (CBD) and probiotic products in the US and Europe Brands widely distributed to around 4,000 retailers spread across all 50 US states Subsidiary Probulin Probiotics is one of the fastest-growing probiotics companies in the US What HempFusion does: HempFusion Wellness Inc (TSE:CBD.U) (OTCMKTS:CBFHF) (FRA:8OO) is a health and wellness supplement company utilizing the power of whole-food hemp nutrition. It manufactures, markets, and sells hemp-based cannabidiol (CBD) and probiotic products in the US and Europe.
CBDHF Financial details
CBDHF Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.01 | 0.03 | 0.03 | 0 | 0 | |
Net income per share | -0.01 | -0.1 | -0.33 | 0 | 0 | |
Operating cash flow per share | -0.02 | -0.1 | -0.13 | 0 | 0 | |
Free cash flow per share | -0.02 | -0.1 | -0.13 | 0 | 0 | |
Cash per share | 0.01 | 0.23 | 0.08 | 0 | 0 | |
Book value per share | 0.03 | 0.26 | -0.03 | 0 | 0 | |
Tangible book value per share | 0.03 | 0.2 | -0.03 | 0 | 0 | |
Share holders equity per share | 0.03 | 0.26 | -0.03 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 213.56M | 213.56M | 213.56M | 0 | 0 | |
Enterprise value | 212.29M | 187.59M | 204.52M | 0 | 0 | |
P/E ratio | -136.32 | -17.57 | -5.63 | 0 | 0 | |
Price to sales ratio | 177.13 | 70.79 | 55.85 | 0 | 0 | |
POCF ratio | -97.23 | -18.24 | -14.37 | 0 | 0 | |
PFCF ratio | -96.68 | -18.08 | -14.13 | 0 | 0 | |
P/B Ratio | 67.3 | 6.91 | -60.38 | 0 | 0 | |
PTB ratio | 67.3 | 6.91 | -60.38 | 0 | 0 | |
EV to sales | 176.08 | 62.19 | 53.49 | 0 | 0 | |
Enterprise value over EBITDA | -148.46 | -14.7 | -11.07 | 0 | 0 | |
EV to operating cash flow | -96.65 | -16.02 | -13.76 | 0 | 0 | |
EV to free cash flow | -96.1 | -15.88 | -13.53 | 0 | 0 | |
Earnings yield | -0.01 | -0.06 | -0.18 | 0 | 0 | |
Free cash flow yield | -0.01 | -0.06 | -0.07 | 0 | 0 | |
Debt to equity | 0 | 0.01 | -0.06 | 0 | 0 | |
Debt to assets | 0 | 0.01 | 0.02 | 0 | 0 | |
Net debt to EBITDA | 0.89 | 2.03 | 0.49 | 0 | 0 | |
Current ratio | 9.34 | 4.99 | 0.78 | 0 | 0 | |
Interest coverage | -10.82 | -686.87 | -463.84 | 0 | 0 | |
Income quality | 1.4 | 0.96 | 0.39 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 1.09 | 1.9 | 2.91 | 0 | 0 | |
Research and developement to revenue | 0 | 0.02 | 0.05 | 0 | 0 | |
Intangibles to total assets | 0 | 0.2 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.01 | 0.01 | 0.02 | 0 | 0 | |
Capex to revenue | -0.01 | -0.03 | -0.07 | 0 | 0 | |
Capex to depreciation | -2.02 | -0.38 | -0.4 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0.04 | 0.92 | 0 | 0 | |
Graham number | 0.09 | 0.79 | 0.47 | 0 | 0 | |
ROIC | -0.48 | -0.4 | 6.28 | 0 | 0 | |
Return on tangible assets | -0.44 | -0.39 | -2.64 | 0 | 0 | |
Graham Net | 0.01 | 0.17 | -0.06 | 0 | 0 | |
Working capital | 3.15M | 24.37M | -3.9M | 0 | 0 | |
Tangible asset value | 3.17M | 23.19M | -3.54M | 0 | 0 | |
Net current asset value | 3.15M | 22.77M | -4.07M | 0 | 0 | |
Invested capital | 0 | 0.01 | -0.06 | 0 | 0 | |
Average receivables | 271.6K | 540.96K | 565.79K | 228.53K | 0 | |
Average payables | 234.34K | 1.02M | 2.06M | 1.16M | 0 | |
Average inventory | 513.86K | 1.28M | 2.17M | 1.29M | 0 | |
Days sales outstanding | 123.33 | 81.62 | 43.63 | 0 | 0 | |
Days payables outstanding | 121.14 | 273.31 | 247.81 | 0 | 0 | |
Days of inventory on hand | 402.76 | 269.14 | 274.71 | 0 | 0 | |
Receivables turnover | 2.96 | 4.47 | 8.37 | 0 | 0 | |
Payables turnover | 3.01 | 1.34 | 1.47 | 0 | 0 | |
Inventory turnover | 0.91 | 1.36 | 1.33 | 0 | 0 | |
ROE | -0.49 | -0.39 | 10.73 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | 0 | 0 | 0 | 0 | 0 | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 0 | 0 | 0 | 0 | 0 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 0 | 0 | 0 | 0 | 0 | |
Tangible asset value | 0 | 0 | 0 | 0 | 0 | |
Net current asset value | 0 | 0 | 0 | 0 | 0 | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CBDHF Frequently Asked Questions
What is Hempfusion Wellness Inc. stock symbol ?
Hempfusion Wellness Inc. is a CA stock , located in Vancouver of Bc and trading under the symbol CBDHF
Is Hempfusion Wellness Inc. stock public?
Yes, Hempfusion Wellness Inc. is a publicly traded company.